The boundary between science fiction and medical reality blurs as companies like Elon Musk's Neuralink make strides in ...

Michael Mager of Precision Neuroscience, a brain implant startup rival to Elon Musk's Neuralink, sounds off on the future of ...

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

Dr. Michelle Tarver, a veteran of the Food and Drug Administration (FDA), has taken charge of the FDA’s device division at a ...

Elon Musk’s backing of Donald Trump’s decisive victory for a second presidency gives the billionaire entrepreneur ...

Neuralink's second brain implant shows promise as the company aims to enhance the quality of life for individuals with spinal ...

The world's richest person could get a lot of help with contracts and regulatory headaches during the Trump administration.

Tom Oxley, the Australian-born chief executive of brain chip company Synchron, has praised ­Donald Trump for having a ...

Elon Musk's support for Trump could lead to significant policy shifts benefiting his companies. His potential role in the new ...

Neuralink has claimed in a tweet that it has finally received approval from the FDA to start a first-in-human clinical trial of its brain implant chip – but hasn’t indicated when it may start.

After becoming one of the president-elect’s most prominent backers on the campaign trail, many are wondering what is in it ...

Elon Musk’s substantial support for Donald Trump’s re-election has the potential to reshape regulatory oversight across his ...